• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ACCU-CHEK INFORM II TEST STRIPS; BLOOD GLUCOSE MONITORING TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ACCU-CHEK INFORM II TEST STRIPS; BLOOD GLUCOSE MONITORING TEST STRIPS Back to Search Results
Catalog Number 05942861001
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/19/2023
Event Type  malfunction  
Event Description
There was an allegation of questionable glucose results from an accu-chek inform ii meter.The meter result was 413 mg/dl at 1:09 pm.The meter result was 140 mg/dl at 1:16 pm.This result was believed to be correct.
 
Manufacturer Narrative
The meter serial number is (b)(6).The customer had not performed qc on the meter due to the display being damaged.No results were misinterpreted.The product was requested for investigation.The meter and test strips were provided for investigation.On a regular basis, inform strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.The investigation is ongoing.
 
Manufacturer Narrative
The meter and test strips were provided for investigation where they were tested.Testing results: (qc range level 1: 30-60 mg/dl; level 2: 261-353 mg/dl).Testing results with the returned meter, retention strips, and retention controls: level 1: 47 mg/dl, 46 mg/dl, 46 mg/dl.Level 2: 317 mg/dl, 317 mg/dl, 314 mg/dl.All results are within acceptable range.No information was provided in the complaint case that would point to a cause for the result discrepancy.Testing with the returned strips was also acceptable.The customer's allegation of questionable results was not observed during testing of returned product, all testing with the returned strips produced acceptable results.This complaint is not verified due to the questionable results allegation not being observed during the investigation of the returned product.Strips batch record review didn't identify any non-conformances issued for this lot related to the customer's allegation.Additionally, retention testing is performed every 3 months an no failures have been observed with this lot.Monitoring for this incident has not exceeded any thresholds or identified any field safety corrective actions.No issues with the meter display were noted during the investigation.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCU-CHEK INFORM II TEST STRIPS
Type of Device
BLOOD GLUCOSE MONITORING TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18631081
MDR Text Key334748227
Report Number1823260-2024-00305
Device Sequence Number1
Product Code LFR
UDI-Device Identifier00365702428102
UDI-Public00365702428102
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K121679
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/02/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05942861001
Device Lot Number670234
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/17/2024
Date Manufacturer Received02/13/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DESCOVY; MEPRON; MYCOSTATIN; NORVASC; TIVICAY; TOPROL-XL; VABRAMYCIN; VALCYTE
Patient Age37 YR
Patient SexMale
Patient Weight64 KG
-
-